This federal contract award, valued at $40,017.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific contract award is for the delivery of Telmisartan 40 mg tablets, a cardiovascular medication, to the DLA. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive federal contract awards demonstrate its critical role in supplying essential medical commodities, including specialty medications, generic drugs, vaccines, syringes, and other medical products, to various federal agencies and healthcare programs.
Generated 1/17/25, 9:13 AM